Immediate Impact
55 standout
Citing Papers
Key Issues as Wearable Digital Health Technologies Enter Clinical Care
2024 Standout
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2023 Standout
Works of Richard Hellmund being referenced
Cost Comparison of Flash Continuous Glucose Monitoring with Self-monitoring of Blood Glucose in Adults with Type 1 or Type 2 Diabetes Using Intensive Insulin—From a US Private Payer Perspective
2020
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Richard Hellmund | 164 | 235 | 57 | 119 | 17 | 387 | |
| L L Adams-Campbell | 143 | 127 | 100 | 134 | 19 | 441 | |
| Pearson Oh | 135 | 123 | 29 | 91 | 25 | 406 | |
| Roger S. Blumenthal | 209 | 208 | 85 | 43 | 12 | 390 | |
| Ciska Buijs | 66 | 75 | 21 | 202 | 14 | 345 | |
| Loretta M. Byrne | 142 | 47 | 40 | 81 | 12 | 385 | |
| Usha Sriram | 103 | 159 | 53 | 164 | 12 | 421 | |
| Ulf Lundstam | 73 | 101 | 161 | 85 | 14 | 453 | |
| Liat Mlynarsky | 139 | 100 | 65 | 38 | 13 | 423 | |
| E. Meneghini | 48 | 134 | 10 | 215 | 24 | 393 | |
| M. Leitch | 31 | 193 | 28 | 133 | 12 | 340 |
All Works
Login with ORCID to disown or claim papers
Loading papers...